# Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers

> **NCT01672996** · PHASE1,PHASE2 · COMPLETED · sponsor: **GE Healthcare** · enrollment: 66 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ioforminol 160 mgI/mL
- **DRUG:** Ioforminol 200 mgI/mL
- **DRUG:** Iopamidol 300 mgI/mL

## Key facts

- **NCT ID:** NCT01672996
- **Lead sponsor:** GE Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2014-05-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01672996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01672996, "Open Label, Randomized Study of Low Concentration Ioforminol Injections for Use in Abdominal CECT in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01672996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*